ASCO GU 2017: Resection margins after radical cystectomy at academic versus community cancer centers. - Session Highlights
This study can be extrapolated to add to an existing body of knowledge on the importance of multidisciplinary care, the role of neoadjuvant chemotherapy and high volume centers in the care for bladder cancer. As more frequently these factors are present in academic centers.
Author: Kyle Scarberry
Written By: Michael J Metcalfe, MD, Fellow of Urologic Oncology Urology, MD Anderson Cancer Center, Houston TX
Ashish M. Kamat, MD, MBBS, FACS, President, International Bladder Cancer Network Chair, Society of Immunotherapy for Cancer (SITC), BCTF, Director of Urologic Oncology Fellowship, Professor of Urology, Attending Surgeon, Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston TX
at the 2017 Genitourinary Cancers Symposium - February 16 - 18, 2017 – Orlando, Florida USA